All In Biotech

Drug Trial Radar · NCT07578116

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

Randomized Phase III Trial of Multimodality Therapy Versus Standard of Care Systemic Therapy in HER2 Positive (HER2+) De Novo (AJCC Stage IV) Oligometastatic Breast Cancer With Response to Initial Chemotherapy

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 562 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

562

Planned (sponsor's estimate)

Start

Mar 9, 2027

Primary completion

May 31, 2032

Study completion May 31, 2033

Sponsor

Lead sponsor
SWOG Cancer Research NetworkResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
May 11, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial evaluates the effect of adding locoregional therapy (surgery and radiation) and metastasis-directed stereotactic body radiation therapy (SBRT) to standard systemic therapy following standard HER2-targeted systemic therapy, compared to standard systemic therapy alone, in treating patients with HER2-positive stage IV breast cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or to a limited number of sites (oligometastatic). The usual approach for patients with (oligo)metastatic HER2-positive breast cancer is systemic drug treatment, which means medicines that travel through the whole body to treat both the breast and any areas where the cancer has spread. There are a number of approved HER2-targeted systemic therapy regimens available to patients. These typically include immunotherapy and/or chemotherapy. Immunotherapy drugs may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Unlike systemic therapy, locoregional therapies like surgery and radiation are focused treatments at the site of disease, delivered with the intent of sparing healthy tissues. Breast surgeries such as breast conserving therapy or total mastectomy are procedures in which the cancerous breast tissue (and healthy breast tissue in the case of total mastectomy) are surgically removed from the body. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. SBRT is a type of external radiation therapy that uses special equipment to position a patient and precisely deliver radiation to tumors in the body (except the brain). The total dose of radiation is divided into smaller doses given over several days. This type of radiation therapy helps spare normal tissue. Adding locoregional therapy, as well as metastasis-directed SBRT, to standard systemic therapy may help patients with (oligo)metastatic, HER2-positive stage IV breast cancer live longer overall or before their cancer progresses, and may help more patients achieve no evidence of disease, when compared to standard systemic therapy alone.

Conditions

  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic HER2-Positive Breast Carcinoma
  • Oligometastatic Breast Carcinoma

Interventions

  • Biopsy ProcedureProcedure

    Undergo biopsy

  • Biospecimen CollectionProcedure

    Undergo collection of blood samples

  • Breast Conservation TreatmentProcedure

    Undergo breast conserving therapy

  • Computed TomographyProcedure

    Undergo CT and/or PET/CT

  • Cyclin-Dependent Kinase 4 InhibitorDrug

    Given CDK4/6 inhibitor

  • Cyclin-Dependent Kinase 6 InhibitorDrug

    Given CDK4/6 inhibitor

  • Echocardiography TestProcedure

    Undergo ECHO

  • HER2-targeted TherapyDrug

    Receive HER2-targeted systemic therapy

  • Hormone TherapyDrug

    Given endocrine therapy

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • MammographyProcedure

    Undergo mammography

  • PertuzumabBiological

    Given pertuzumab

  • Positron Emission TomographyProcedure

    Undergo PET/CT

  • Radiation BoostRadiation

    Undergo RT boost

  • Radiation TherapyRadiation

    Undergo RT

  • Stereotactic Body Radiation TherapyRadiation

    Undergo SBRT

  • Stereotactic RadiosurgeryRadiation

    Undergo SRS/SRT

  • Taxane CompoundDrug

    Given taxane therapy

  • Total MastectomyProcedure

    Undergo total mastectomy

  • TrastuzumabBiological

    Given trastuzumab

  • Trastuzumab DeruxtecanBiological

    Given T-DXd

  • Trastuzumab EmtansineBiological

    Given T-DM1

  • Ultrasound ImagingProcedure

    Undergo ultrasound

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall survival (OS) (Cohort A)Time frame: From date of Step 2 registration to date of death, assessed up to 10 years
  2. Progression-free survival (PFS) (Observational Cohort B)Time frame: From date of Step 2 registration to date of first documentation of progression or recurrence or death, assessed at 3 and 5 years
  3. Overall survival (Observational Cohort B)Time frame: From date of Step 2 registration to date of death, assessed at 3 and 5 years

Locations

59 sites in 1 country. Site status is shown where the registry gives one.

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro

    Jonesboro, Arkansas · Recruiting

  • Smilow Cancer Hospital-Derby Care Center

    Derby, Connecticut · Recruiting

  • Smilow Cancer Hospital Care Center-Fairfield

    Fairfield, Connecticut · Recruiting

  • Smilow Cancer Hospital Care Center at Greenwich

    Greenwich, Connecticut · Recruiting

  • Smilow Cancer Hospital Care Center - Guilford

    Guilford, Connecticut · Recruiting

  • Smilow Cancer Hospital-Hamden Care Center

    Hamden, Connecticut · Recruiting

  • Smilow Cancer Center/Yale-New Haven Hospital

    New Haven, Connecticut · Recruiting

  • Yale University

    New Haven, Connecticut · Recruiting

  • Yale-New Haven Hospital North Haven Medical Center

    North Haven, Connecticut · Recruiting

  • Smilow Cancer Hospital Care Center at Long Ridge

    Stamford, Connecticut · Recruiting

  • Smilow Cancer Hospital-Torrington Care Center

    Torrington, Connecticut · Recruiting

  • Smilow Cancer Hospital Care Center-Trumbull

    Trumbull, Connecticut · Recruiting

  • Smilow Cancer Hospital-Waterbury Care Center

    Waterbury, Connecticut · Recruiting

  • Smilow Cancer Hospital Care Center - Waterford

    Waterford, Connecticut · Recruiting

  • Orlando Health Cancer Institute

    Orlando, Florida · Recruiting

  • OSF Saint Joseph Medical Center

    Bloomington, Illinois · Recruiting

  • Illinois CancerCare-Bloomington

    Bloomington, Illinois · Recruiting

  • Illinois CancerCare-Canton

    Canton, Illinois · Recruiting

  • Illinois CancerCare-Carthage

    Carthage, Illinois · Recruiting

  • Cancer Care Specialists of Illinois - Decatur

    Decatur, Illinois · Recruiting

  • Decatur Memorial Hospital

    Decatur, Illinois · Recruiting

  • Illinois CancerCare-Eureka

    Eureka, Illinois · Recruiting

  • Illinois CancerCare-Galesburg

    Galesburg, Illinois · Recruiting

  • Illinois CancerCare-Kewanee Clinic

    Kewanee, Illinois · Recruiting

  • Illinois CancerCare-Macomb

    Macomb, Illinois · Recruiting

  • Cancer Care Center of O'Fallon

    O'Fallon, Illinois · Recruiting

  • HSHS Saint Elizabeth's Hospital

    O'Fallon, Illinois · Recruiting

  • Illinois CancerCare-Ottawa Clinic

    Ottawa, Illinois · Recruiting

  • Illinois CancerCare-Pekin

    Pekin, Illinois · Recruiting

  • Illinois CancerCare-Peoria

    Peoria, Illinois · Recruiting

  • OSF Saint Francis Radiation Oncology at Peoria Cancer Center

    Peoria, Illinois · Recruiting

  • OSF Saint Francis Medical Center

    Peoria, Illinois · Recruiting

  • Illinois CancerCare-Peru

    Peru, Illinois · Recruiting

  • Illinois CancerCare-Princeton

    Princeton, Illinois · Recruiting

  • Southern Illinois University School of Medicine

    Springfield, Illinois · Recruiting

  • Springfield Clinic

    Springfield, Illinois · Recruiting

  • Springfield Memorial Hospital

    Springfield, Illinois · Recruiting

  • Illinois CancerCare - Washington

    Washington, Illinois · Recruiting

  • Mercy Cancer Center-West Lakes

    Clive, Iowa · Recruiting

  • Iowa Methodist Medical Center

    Des Moines, Iowa · Recruiting

Showing 40 of 59 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.